Asthma is a common health condition, affecting more than 5.4 million people in the UK. Around one in 12 adults and one in 11 children are currently receiving treatment for asthma. 6.5% of all people in England registered with a GP have a record of asthma.
Asthma has a huge impact on the lives of patients and leads to 60,000 hospital admissions each year. Severe asthma attacks can be potentially life-threatening and three people in the UK each day die of an asthma attack. (Source: British Lung Foundation)
However, many asthma attacks could be avoided through improvements to asthma care including early diagnosis, improved treatment, and self-management education. Asthma and respiratory disease are a key clinical priority for the NHS, as identified in the NHS Long Term Plan.
As a key partner of NHS England’s Accelerated Access Collaborative (AAC), the Health Innovation Network has supported the roll-out of Fractional exhaled Nitric Oxide (FeNO) testing as part of the AAC Rapid Uptake Products (RUP) programme.